Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EIT detection of phrenic nerve block after suprascapular vs interscalene block in shoulder surgery
DRKS00011787Phase 4Completed
- Sponsor
- ACQUA Klinik
- Start
- May 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ropivacaine in postoperative pain (2 arms), sponsored by ACQUA Klinik. Primary endpoint: Detection of phrenic nerve block by EIT after SSNB vs ISB. Started May 2017; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on DRKS00011787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00011787.